The number of T1 hypointensities at baseline and increases in black-hole volumes on magnetic resonance imaging predict worsening on the Expanded Disability Status Scale.
In patients with multiple sclerosis (MS), T2 hyperintense brain lesions represent focal areas of inflammation, demyelination, axonal injury, and gliosis. Chronic T1 hypointense lesions are a subset of T2 lesions that represent the most severe tissue injury, with loss of axons and cellular matrix. Short-term studies have conflicted regarding the importance of these T1 hypointensities in patients with relapsing-remitting MS. Now, investigators present long-term data in a cohort with a mean 5 years' disease duration at recruitment. The same magnetic resonance imaging (MRI) scanner and sequences were used for 57 patients.
During 10 years of follow-up, the mean Expanded Disability Status Scale (EDSS) score increased from 1.8 to 2.5. Mean T2 lesio…
Reviewing Author
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)